Shari Fechner
Nurse Practitioner · Rapid City, SDNPI 1255301305
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Amgen accounts for 75.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $2,085 and has fallen 90.5% since, to $198 in 2025. Among nurse practitioner clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $54.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- UCB, Inc.$328
- Aurinia Pharma U.S., Inc.$164
- Mallinckrodt Hospital Products Inc.$155
- AbbVie$134
- Johnson & Johnson$86
- plus $232 from 9 others
What the payments were for
- Consulting fees$2,66259%
- Food & beverage$1,70638%
- Education$1163%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 37 | $3,386 |
| UCB, Inc. | 14 | $328 |
| Aurinia Pharma U.S., Inc. | 3 | $164 |
| Mallinckrodt Hospital Products Inc. | 3 | $155 |
| AbbVie | 6 | $134 |
| Johnson & Johnson | 5 | $86 |
| Radius Health, Inc. | 3 | $50 |
| Novartis | 2 | $31 |
| Pfizer | 2 | $30 |
| Lilly USA, LLC | 2 | $26 |
| Genentech USA, Inc. | 2 | $25 |
| Pharming Healthcare, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| GSK | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,484 in reported general payments places this provider in the 95th percentile of 504 nurse practitioner providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 24 | $217,809 |
| ForteoTeriparatide | 36 | $150,393 |
| Enbrel SureclickEtanercept | 20 | $143,689 |
| SimponiGolimumab | 13 | $125,213 |
| Xeljanz XrTofacitinib Citrate | 19 | $104,051 |
| RinvoqUpadacitinib | 13 | $78,735 |
| MethotrexateMethotrexate Sodium | 306 | $11,091 |
| Hydroxychloroquine Sulfate | 225 | $9,579 |
| Leflunomide | 142 | $9,241 |
| Celecoxib | 38 | $3,363 |
| Sulfasalazine DrSulfasalazine | 69 | $3,167 |
| Prednisone | 238 | $2,506 |
| Azathioprine | 41 | $2,253 |
| Duloxetine Hcl | 117 | $1,543 |
| Sulfasalazine | 32 | $1,192 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCForteo | $26 | $150,39336 claims |
| Johnson & JohnsonSimponi | $86 | $125,21313 claims |
| AbbVieRinvoq | $134 | $78,73513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 504 nurse practitioner providers in South Dakota.
Other nurse practitioner in Rapid City
- Roger DeraadRapid City$6K
- Kristen NelsonRapid City$5K
- Caiti KeanRapid City$5K
- Becky SharpRapid City$4K
- Michele DelzerRapid City$3K
- Marie PattonRapid City$3K
- Joel KirstRapid City$3K
- Christina GrahamRapid City$3K
- Connie TschetterRapid City$3K
- Kristine LarsonRapid City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.